Search
TZP-102
go.drugbank.com/drugs/DB16129InvestigationalTZP-102 is under investigation in clinical trial NCT01452815 (Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis).
Sodium iodide
go.drugbank.com/drugs/DB11119ApprovedInvestigationalRadiolabelled compound, [DB09293], is used as a diagnostic tool to evaluate thyroid function and morphology. … Sodium iodide is a source of iodine and can be administered as a supplement for total parenteral nutrition [L2065] but is more commonly used in veterinary medicine.
Mixtures: Micro+ Te PediatricProducts: Sodium Iodide Inj 100mg/ml, TAEK-PHT 123I-NAI (SODYUM İYODÜR) 37 MBQ/ML I.V. ENJEKSİYONLUK ÇÖZELTİ İÇEREN FLAKON, 1 ADETXylose
go.drugbank.com/drugs/DB09419ApprovedWithdrawnXylose has also been used as a diagnostic agent to observe malabsorption. Reduction of xylose by catalytic hydrogenation produces the common food additive sweetener substitute xylitol [DB11195]. … The dextrorotary form of xylose, D-xylose, refers usually to the endogenously occurring form of the sugar in living things. The levorotary form, L-xylose, can refer to the form that is synthesized.
Products: Xylo-tol Pwr 25gm/pckATL-104
go.drugbank.com/drugs/DB05670InvestigationalATL-104 is a potent mitogen for epithelial cells of the gastrointestinal tract. In animal models, ATL-104 aids regeneration of the gastrointestinal tract after treatment with chemotherapeutic agents.
SRN-101
go.drugbank.com/drugs/DB33962ExperimentalSRN-101 is under investigation in clinical trial NCT07826949 (A Phase 1 Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma.). … SRN-101 is a biologic drug.
Lesinidase alfa
go.drugbank.com/drugs/DB15267InvestigationalLesinidase alfa is under investigation in clinical trial NCT02324049 (Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 in Mucopolysaccharidosis III, Type B (MPS IIIB)).
Synonyms: SBC-103Apazunersen
go.drugbank.com/drugs/DB16981InvestigationalApazunersen is an antisense oligonucleotide designed to target and inhibit the expression of UBE3A-AS. It is being investigated for the treatment of Angelman Syndrome.[L46772]
Categories: Antisense Oligonucleotide Specific to the Antisense Transcript of UBE3ASynonyms: GTX 102Carbomer
go.drugbank.com/drugs/DB15649InvestigationalProducts: VISCOTEARS STERİL OFTALMİK JEL, 10 G, THILO-TEARS 10 GR JELAV-101
go.drugbank.com/drugs/DB12878InvestigationalAV-101 has been used in trials studying the treatment of Neuropathic Pain.